Dynavax Technologies Corporation (NASDAQ:DVAX) is a biopharmaceutical company that discovers and develops products to prevent and treat infectious diseases, asthma and inflammatory and autoimmune diseases. Dynavax Technologies Corporation achieved its new 52 week high price of $4.21 where it was opened at $3.70 UP 0.40 points or +10.87% by closing at $4.08.

Dynavax Technologies Corporation (NASDAQ:DVAX) witnessed volume of 6.79 million shares during last trade however it holds an average trading capacity of 1.73 million shares. DVAX last trade opened at $3.05 reached intraday low of $2.94 and went +0.33% up to close at $3.07.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6939

Dynavax Technologies Corporation (NASDAQ:DVAX) witnessed volume of 6.79 million shares during last trade however it holds an average trading capacity of 1.73 million shares. DVAX last trade opened at $3.05 reached intraday low of $2.94 and went +0.33% up to close at $3.07.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6939

Dynavax Technologies Corporation (NASDAQ:DVAX) witnessed volume of 4.82 million shares during last trade however it holds an average trading capacity of 1.20 million shares. DVAX last trade opened at $2.85 reached intraday low of $2.34 and went -1.43% down to close at $2.75.